Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial

Abstract Background Dairy products are a major contributor to dietary SFA. Partial replacement of milk SFA with unsaturated fatty acids (FAs) is possible through oleic-acid rich supplementation of the dairy cow diet. To assess adherence to the intervention of SFA-reduced, MUFA-enriched dairy product...

Full description

Bibliographic Details
Main Authors: Oonagh Markey, Dafni Vasilopoulou, Kirsty E. Kliem, Albert Koulman, Colette C. Fagan, Keith Summerhill, Laura Y. Wang, Alistair S. Grandison, David J. Humphries, Susan Todd, Kim G. Jackson, David I. Givens, Julie A. Lovegrove
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Nutrition Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12937-017-0249-2
id doaj-e1a14b3adaeb4711983cd1eda6b02a91
record_format Article
spelling doaj-e1a14b3adaeb4711983cd1eda6b02a912020-11-25T00:32:15ZengBMCNutrition Journal1475-28912017-05-0116111510.1186/s12937-017-0249-2Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trialOonagh Markey0Dafni Vasilopoulou1Kirsty E. Kliem2Albert Koulman3Colette C. Fagan4Keith Summerhill5Laura Y. Wang6Alistair S. Grandison7David J. Humphries8Susan Todd9Kim G. Jackson10David I. Givens11Julie A. Lovegrove12Hugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic Research, University of ReadingHugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic Research, University of ReadingAnimal, Dairy and Food Chain Sciences, University of ReadingMRC Elsie Widdowson LaboratoryDepartment of Food and Nutritional Sciences, University of ReadingMRC Elsie Widdowson LaboratoryMRC Elsie Widdowson LaboratoryDepartment of Food and Nutritional Sciences, University of ReadingAnimal, Dairy and Food Chain Sciences, University of ReadingDepartment of Mathematics and Statistics, School of Mathematical, Physical and Computational Sciences, University of ReadingHugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic Research, University of ReadingInstitute for Food, Nutrition and Health, University of ReadingHugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic Research, University of ReadingAbstract Background Dairy products are a major contributor to dietary SFA. Partial replacement of milk SFA with unsaturated fatty acids (FAs) is possible through oleic-acid rich supplementation of the dairy cow diet. To assess adherence to the intervention of SFA-reduced, MUFA-enriched dairy product consumption in the RESET (REplacement of SaturatEd fat in dairy on Total cholesterol) study using 4-d weighed dietary records, in addition to plasma phospholipid FA (PL-FA) status. Methods In a randomised, controlled, crossover design, free-living UK participants identified as moderate risk for CVD (n = 54) were required to replace habitually consumed dairy foods (milk, cheese and butter), with study products with a FA profile typical of retail products (control) or SFA-reduced, MUFA-enriched profile (modified), for two 12-week periods, separated by an 8-week washout period. A flexible food-exchange model was used to implement each isoenergetic high-fat, high-dairy diet (38% of total energy intake (%TE) total fat): control (dietary target: 19%TE SFA; 11%TE MUFA) and modified (16%TE SFA; 14%TE MUFA). Results Following the modified diet, there was a smaller increase in SFA (17.2%TE vs. 19.1%TE; p < 0.001) and greater increase in MUFA intake (15.4%TE vs. 11.8%TE; p < 0.0001) when compared with the control. PL-FA analysis revealed lower total SFAs (p = 0.006), higher total cis-MUFAs and trans-MUFAs (both p < 0.0001) following the modified diet. Conclusion The food-exchange model was successfully used to achieve RESET dietary targets by partial replacement of SFAs with MUFAs in dairy products, a finding reflected in the PL-FA profile and indicative of objective dietary compliance. Trial registration ClinicalTrials.gov Identifier: NCT02089035 , date 05-01-2014.http://link.springer.com/article/10.1186/s12937-017-0249-2Cardiovascular diseaseDairy productsDietary fat compositionFood-exchange modelFatty acidsMonounsaturated fatty acids
collection DOAJ
language English
format Article
sources DOAJ
author Oonagh Markey
Dafni Vasilopoulou
Kirsty E. Kliem
Albert Koulman
Colette C. Fagan
Keith Summerhill
Laura Y. Wang
Alistair S. Grandison
David J. Humphries
Susan Todd
Kim G. Jackson
David I. Givens
Julie A. Lovegrove
spellingShingle Oonagh Markey
Dafni Vasilopoulou
Kirsty E. Kliem
Albert Koulman
Colette C. Fagan
Keith Summerhill
Laura Y. Wang
Alistair S. Grandison
David J. Humphries
Susan Todd
Kim G. Jackson
David I. Givens
Julie A. Lovegrove
Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
Nutrition Journal
Cardiovascular disease
Dairy products
Dietary fat composition
Food-exchange model
Fatty acids
Monounsaturated fatty acids
author_facet Oonagh Markey
Dafni Vasilopoulou
Kirsty E. Kliem
Albert Koulman
Colette C. Fagan
Keith Summerhill
Laura Y. Wang
Alistair S. Grandison
David J. Humphries
Susan Todd
Kim G. Jackson
David I. Givens
Julie A. Lovegrove
author_sort Oonagh Markey
title Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
title_short Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
title_full Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
title_fullStr Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
title_full_unstemmed Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
title_sort plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial
publisher BMC
series Nutrition Journal
issn 1475-2891
publishDate 2017-05-01
description Abstract Background Dairy products are a major contributor to dietary SFA. Partial replacement of milk SFA with unsaturated fatty acids (FAs) is possible through oleic-acid rich supplementation of the dairy cow diet. To assess adherence to the intervention of SFA-reduced, MUFA-enriched dairy product consumption in the RESET (REplacement of SaturatEd fat in dairy on Total cholesterol) study using 4-d weighed dietary records, in addition to plasma phospholipid FA (PL-FA) status. Methods In a randomised, controlled, crossover design, free-living UK participants identified as moderate risk for CVD (n = 54) were required to replace habitually consumed dairy foods (milk, cheese and butter), with study products with a FA profile typical of retail products (control) or SFA-reduced, MUFA-enriched profile (modified), for two 12-week periods, separated by an 8-week washout period. A flexible food-exchange model was used to implement each isoenergetic high-fat, high-dairy diet (38% of total energy intake (%TE) total fat): control (dietary target: 19%TE SFA; 11%TE MUFA) and modified (16%TE SFA; 14%TE MUFA). Results Following the modified diet, there was a smaller increase in SFA (17.2%TE vs. 19.1%TE; p < 0.001) and greater increase in MUFA intake (15.4%TE vs. 11.8%TE; p < 0.0001) when compared with the control. PL-FA analysis revealed lower total SFAs (p = 0.006), higher total cis-MUFAs and trans-MUFAs (both p < 0.0001) following the modified diet. Conclusion The food-exchange model was successfully used to achieve RESET dietary targets by partial replacement of SFAs with MUFAs in dairy products, a finding reflected in the PL-FA profile and indicative of objective dietary compliance. Trial registration ClinicalTrials.gov Identifier: NCT02089035 , date 05-01-2014.
topic Cardiovascular disease
Dairy products
Dietary fat composition
Food-exchange model
Fatty acids
Monounsaturated fatty acids
url http://link.springer.com/article/10.1186/s12937-017-0249-2
work_keys_str_mv AT oonaghmarkey plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT dafnivasilopoulou plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT kirstyekliem plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT albertkoulman plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT colettecfagan plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT keithsummerhill plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT lauraywang plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT alistairsgrandison plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT davidjhumphries plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT susantodd plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT kimgjackson plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT davidigivens plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
AT juliealovegrove plasmaphospholipidfattyacidprofileconfirmscompliancetoanovelsaturatedfatreducedmonounsaturatedfatenricheddairyproductinterventioninadultsatmoderatecardiovascularriskarandomizedcontrolledtrial
_version_ 1725320099040067584